Page Nav

HIDE

Pages

Breaking News:

latest

Ads Place

Europe evaluates vaccinating children from 12 years of age

Europe is evaluating the possibility of vaccinating children from the age of 12 against Covid-19.   The European Medicines Agency is rev...





Europe is evaluating the possibility of vaccinating children from the age of 12 against Covid-19.

 

The European Medicines Agency is reviewing an application from Pfizer / bioNtech that until now was only authorized from the age of 16. If approved, it could be available this summer.

 

This is how they reacted on the streets of Brussels:

 

"I think that if they put these vaccines on the market it means that they have been tested and validated. We are not going to put the population at risk, so I am not afraid," says Anne-Sophie Braquart, pregnant and mother of twins.

 

"I am already against the vaccine. And for my children I am even more against it. Especially when I hear everything that is happening in the world with vaccination problems, says Olivier Aerts, father of two boys.

 

The Johnson & Johnson and AstraZeneca vaccines have caused some rare side effects, but so far the messenger RNA technology, used by Pfizer / bioNtech, has not caused complications.

 

According to researcher Sophie Lucas, an immunologist at the Duve Institute-UCLouvain, there is no indication that children are at higher risk. "There are no particular theoretical risks. We are currently considering the possibility of extending vaccination to children between 12 and 15 years old because we have the results of a clinical study that shows that the benefits are interesting in this segment of the population, and to a large extent higher than the risks that have been observed. "

 

Pfizer says that clinical trials conducted on more than 2,000 young people between the ages of 12 and 15 show that its vaccine is 100% effective.

 

It is also true that few children have had serious complications due to Covid-19, but the researcher argues that vaccinating them also serves to prevent the virus from spreading. "If you leave the transmission of the virus at a very high level, the probability that at some point variants will emerge capable of resisting pre-existing immunity," adds Lucas.

 

The Pfizer / BioNTech vaccine is also being tested in children between the ages of 6 months and 12 years. If the results are conclusive, they could be inoculated next year.

No comments

Publicidad